text_1: Fibroblast growth factor 21 protects against atherosclerosis by modulating adiponectin and SREBP2 levels.
text_2: It acts as a key downstream target of both peroxisome proliferator-activated receptor α and γ, the agonists of which have been used for lipid lowering and insulin sensitization, respectively.